The scheme unraveled on a Saturday when Staff F called the director of nursing about a taped medication. Staff F examined the pill, punched it out of its packaging, and immediately noticed something wrong.
"It looked a lot like Oxycodone, and it was not Oxycodone," the director of nursing told federal inspectors during an October complaint investigation at New London Specialty Care.
Staff F looked up the pill and identified it as amlodipine. The medication had been prescribed for Resident #1.
The director of nursing launched an investigation, interviewing multiple staff members who had worked Friday and overnight shifts. All denied taping medications.
Only two people had access to that particular medication cart. One was Staff F, who had discovered and reported the problem.
The other was Staff A.
The assistant director of nursing had previously spoken to Staff A about taping medications, according to the director of nursing's account to inspectors. This prior warning became crucial evidence in the investigation.
Staff A later admitted to getting in trouble for taping and wasting narcotics, though this information didn't reach the director of nursing until Saturday when Staff F made the discovery.
The facility's internal investigation concluded that Staff A was responsible for the drug diversion. She was suspended during the investigation and terminated when the findings confirmed her involvement.
Federal inspectors reviewed the facility's policy on investigating theft and misappropriation of resident property, revised in April 2021. The policy states that residents have the right to be free from exploitation, theft, and misappropriation of personal property.
The drug substitution violated federal regulations requiring nursing homes to ensure residents receive their prescribed medications safely and accurately. When a controlled substance like oxycodone is diverted, residents may experience untreated pain while staff members potentially abuse the stolen medication.
Oxycodone is a powerful opioid painkiller frequently targeted for diversion in healthcare settings. Amlodipine, the blood pressure medication found in its place, would provide no pain relief to a resident prescribed oxycodone for legitimate medical needs.
The taping method Staff A allegedly used involves covering medication packages with tape, often to conceal that pills have been removed or substituted. This technique allows diverters to make packages appear unopened while accessing the contents.
Drug diversion in nursing homes poses serious risks to vulnerable residents who depend on staff for proper medication administration. Elderly residents may be unable to advocate for themselves when experiencing untreated pain or other symptoms from missing medications.
The investigation revealed systemic problems with medication security at the facility. Multiple staff members had to be interviewed about the Friday and overnight shifts, suggesting the diversion could have occurred during a window when oversight was limited.
Staff A's admission that she "got in trouble" for taping and wasting narcotics indicates this may not have been an isolated incident. The assistant director of nursing's previous conversation with her about medication taping suggests facility leadership was already aware of concerning behavior.
The Saturday discovery by Staff F prevented further diversion from occurring, but federal inspectors found the facility failed to adequately protect residents from exploitation and theft of their prescribed medications.
The investigation classified the violation as causing minimal harm or potential for actual harm, affecting some residents. However, for Resident #1, the substitution meant receiving ineffective medication instead of prescribed pain relief.
New London Specialty Care's failure to prevent the drug diversion violated federal requirements that nursing homes maintain systems to protect residents from exploitation and ensure proper medication administration. The facility's policy acknowledged residents' rights to be free from such theft, but the actual protections proved inadequate.
The termination of Staff A removed the immediate threat, but the case highlighted vulnerabilities in the facility's medication security protocols that allowed the diversion to occur in the first place.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for New London Specialty Care from 2025-10-14 including all violations, facility responses, and corrective action plans.